FGF21 and type 2 diabetes mellitus: In the near future, new molecules, such as the analogs of hepatokine, fibroblast growth factor 21 (FGF21), capable of modulating the metabolic profile (glucose and lipid metabolism) in an earlier stage of the disease, prior to overt type 2 diabetes (T2D), will become available [17,18,19].